Moreover, HNF3γ promotes the expressions of OATP1B1 and OATP1B3, two major membrane transporters responsible for sorafenib uptake, thus sensitizing HCC cells to the treatment with sorafenib (Zhou et al., 2020). The gene discussed is SLCO1B1; the disease is hepatocellular carcinoma.